Oligohydramnios associated with administration of weekly paclitaxel for triple-negative breast cancer during pregnancy

Annals of Oncology

Volumn 22, Issue 9, 2011, Pages 2151-2152

  Shieh, M P ^a,b   Mehta, R S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; GRANULOCYTE COLONY STIMULATING FACTOR; PACLITAXEL; PROGESTERONE RECEPTOR;

ADULT; AXILLARY LYMPH NODE; CASE REPORT; CESAREAN SECTION; DRUG SAFETY; FEMALE; FETUS DEVELOPMENT; FETUS ECHOGRAPHY; FETUS GROWTH; GESTATIONAL AGE; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; LETTER; MULTIPLE CYCLE TREATMENT; OLIGOHYDRAMNIOS; PREGNANCY; PRIORITY JOURNAL; TRIPLE NEGATIVE BREAST CANCER; TUMOR GROWTH; TUMOR VOLUME;

EID: 80052414315     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr339     Document Type: Letter

References (5)

1. Mehta RS. Dose-dense and/or metronomic schedules of specific chemotherapies consolidate the chemosensitivity of triple-negative breast cancer: a step toward reversing triple-negative paradox. J Clin Oncol 2008; 26(19): 3286-3288; author reply 3288, 2008. Incorporated into NCI PDQ guidelines. http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/page8 (1 July 2011, date last accessed).
2. Cardonick EH, Gilmandyr D. Maternal and neonatal outcomes of dose dense chemotherapy for breast cancer in pregnancy. Poster session presented at: San Antonio Breast Cancer Symposium; 2010 December 8-12; San Antonio, TX.
3. Sparano JA, Wang M, Martino S. et al. Weekly paclitaxel in the adjuvant treatment of breast cancer. N Engl J Med 2008; 358: 1663-1671.
4. Mir O, Berveiller P, Goffinet F. et al. Taxanes for breast cancer during pregnancy: a systematic review. Ann Oncol 2010; 21(2): 425-426.
5. Bader AA, Schlembach D, Tamussino KF. et al. Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy. Lancet Oncol 2007; 8(1): 79-81.